D89.40 Billable / specific Mast cell activation, unspecified

ICD-10-CM D89.40 identifies “Mast cell activation, unspecified” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapter 3: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Code-level instructions

Inclusion terms2
  • Mast cell activation disorder, unspecified
  • Mast cell activation syndrome, NOS

Inherited instructions

Chapters 3 · Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)

Excludes 29
  • autoimmune disease (systemic) NOS (M35.9)
  • certain conditions originating in the perinatal period (P00-P96)
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
  • endocrine, nutritional and metabolic diseases (E00-E88)
  • human immunodeficiency virus [HIV] disease (B20)
  • injury, poisoning and certain other consequences of external causes (S00-T88)
  • neoplasms (C00-D49)
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)

D80-D89 · Certain disorders involving the immune mechanism (D80-D89)

Includes3
  • defects in the complement system
  • immunodeficiency disorders, except human immunodeficiency virus [HIV] disease
  • sarcoidosis
Excludes 12
  • autoimmune disease (systemic) NOS (M35.9)
  • functional disorders of polymorphonuclear neutrophils (D71-)
Excludes 21

human immunodeficiency virus [HIV] disease (B20)

D89 · Other disorders involving the immune mechanism, not elsewhere classified

Excludes 12
  • hyperglobulinemia NOS (R77.1)
  • monoclonal gammopathy (of undetermined significance) (D47.2)
Excludes 21

transplant failure and rejection (T86.-)

D89.4 · Mast cell activation syndrome and related disorders

Excludes 111
  • aggressive systemic mastocytosis (C96.21)
  • congenital cutaneous mastocytosis (Q82.2)
  • (non-congenital) cutaneous mastocytosis (D47.01)
  • (indolent) systemic mastocytosis (D47.02)
  • malignant mast cell neoplasm (C96.2-)
  • malignant mastocytoma (C96.29)
  • mast cell leukemia (C94.3-)
  • mast cell sarcoma (C96.22)
  • mastocytoma NOS (D47.09)
  • other mast cell neoplasms of uncertain behavior (D47.09)
  • systemic mastocytosis associated with a clonal hematologic non-mast cell lineage disease (SM-AHNMD) (D47.02)
Official index references

Official index references (1)

Activation (1)

Official conversion history

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Release dates 2016-10-01

Previous assignment: D89.89

History

Code history

Latest recorded change · FY2027

ChangedUnchanged
FY2027Selected edition

Effective from

  • Inherited rules changed

Mast cell activation, unspecified

Billable diagnosis code

CDC/NCHS · FY2027

All editions (18)

All editionsEffective fromCode history
FY20172016-10-01Added
FY20182017-10-01Inherited rules changed
FY20192018-10-01No tabular change
FY20202019-10-01No tabular change
FY2020 · April2020-04-01No tabular change
FY20212020-10-01No tabular change
FY2021 · 01-012021-01-01No tabular change
FY20222021-10-01No tabular change
FY2022 · 04-012022-04-01No tabular change
FY20232022-10-01No tabular change
FY2023 · 04-012023-04-01No tabular change
FY20242023-10-01No tabular change
FY2024 · 04-012024-04-01No tabular change
FY20252024-10-01No tabular change
FY2025 · 04-012025-04-01No tabular change
FY20262025-10-01Inherited rules changed
FY2026 · April2026-04-01No tabular change
FY20272026-10-01Inherited rules changed
Historical ICD-9 mappings · 2018

Historical mapping only; not an automatic code substitution.

  • 279.8 · Approximate

This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.